Sunday, 24 February 2019

Pharma News

  • Kyowa Hakko Kirin initiates Ph 2 Clinical Study of Tenapanor

    Pharma |  News | 0 Comment | 08 Feb, 2019

    Kyowa Hakko Kirin Co., Ltd. announced the initiation of a phase 2 clinical study in Japan for tenapanor, a small molecule compound licensed from Ardelyx, Inc. Tenapanor is an oral, mini...Read more

  • Eiger BioPharma gets patent protection for HDV drug in Europe and Japan

    Pharma |  News | 0 Comment | 08 Feb, 2019

    Eiger BioPharmaceuticals, Inc., focused on the development and commercialization of targeted therapies for rare and ultra-rare diseases, has announced that the European Patent Office and th...Read more

  • FDA approves Sanofi's blood disorder drug

    Pharma |  News | 0 Comment | 07 Feb, 2019

    The U.S. Food and Drug Administration (FDA) has approved Cablivi (caplacizumab-yhdp) in combination with plasma exchange and immunosuppression for the treatment of acquired thrombotic ...Read more

  • Roche & Chugai join WFH aid programme

    Pharma |  News | 0 Comment | 07 Feb, 2019

    Chugai Pharmaceutical has announced that Roche has joined the World Federation of Hemophilia (WFH) Humanitarian Aid Program, an initiative leading the effort to change the lack of acce...Read more

  • Glenmark Pharma signs an agreement with Grandpharma

    Pharma |  News | 0 Comment | 07 Feb, 2019

    Glenmark Pharmaceuticals Ltd. (Glenmark) has announced that its Swiss subsidiary, Glenmark Specialty S.A., has entered into an exclusive licensing agreement with Grandpharma (China) Co. Ltd...Read more

  • GSK collaborates with Merck for cancer immunotherapy

    Pharma |  News | 0 Comment | 06 Feb, 2019

    GlaxoSmithKline and Merck KGaA, Darmstadt, Germany have announced that they have entered into a global strategic alliance to jointly develop and commercialise M7824 (bintrafusp alfa) M7824...Read more

  • Taiho Pharma teams up with Cullinan Oncology

    Pharma |  News | 0 Comment | 05 Feb, 2019

    Taiho Pharmaceutical and Cullinan Oncology, LLC announced an agreement to develop TAS6417, a novel EGFR (epidermal growth factor receptor) tyrosine kinase inhibitor discovered by Taiho Phar...Read more

  • BioLineRx announces underwritten public offering of its ADS

    Pharma |  News | 0 Comment | 05 Feb, 2019

    An Israel based BioLineRx Ltd., a clinical-stage biopharmaceutical company focused on oncology and immunology, has announced that it has commenced an underwritten public offering of America...Read more

  • Positive CHMP opinion for Chugai’s Hemlibra

    Pharma |  News | 0 Comment | 04 Feb, 2019

    Chugai Pharmaceutical  has announced that Roche has received notification that the EU Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for Hemlibra®...Read more

  • Fortress Biotech announces strategic partnership with Alexion Pharma

    Pharma |  News | 0 Comment | 04 Feb, 2019

    Biopharma company, Fortress Biotech dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products has announced that Caelum Biosciences has signed a...Read more

  • Alkermes announces rejection of ALKS 5461 NDA

    Pharma |  News | 0 Comment | 04 Feb, 2019

    Alkermes plc has announced that it received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for ALKS 5461 for the ...Read more

  • Strides to exit investment in Arrow

    Pharma |  News | 0 Comment | 04 Feb, 2019

    Strides Pharma Science Limited (Strides) has announced that its step-down subsidiary Strides Pharma Global Pte, Limited, has approved the sale of its entire Australian business (Including A...Read more

  • J&J collaborates with MeiraGTx

    Pharma |  News | 0 Comment | 01 Feb, 2019

    The Janssen Pharmaceutical Companies of Johnson & Johnson has announced a worldwide collaboration and license agreement with MeiraGTx Holdings, a clinical-stage gene therapy company, to...Read more

  • Hitachi to acquire apceth Biopharma

    Pharma |  News | 0 Comment | 01 Feb, 2019

    apceth Biopharma GmbH, a contract manufacturing organization in the field of cell and gene therapy has announced that Hitachi Chemical Co., Ltd. will enter into an agreement to acquire all ...Read more

  • I Holland to conduct seminar on problems in tablet production

    Pharma |  News | 0 Comment | 31 Jan, 2019

    I Holland, leaders in the manufacture of tablet tooling for the pharmaceutical and nutraceutical markets is pleased to announce that the company is hosting the ‘Ultimate Gui...Read more

  • ASLAN Pharma reveals strategies of clinical development programs

    Pharma |  News | 0 Comment | 30 Jan, 2019

    ASLAN Pharmaceuticals announced a strategic corporate restructuring to focus its resources on its lead clinical programs: varlitinib in biliary tract cancer (BTC), ASLAN003 i...Read more

  • Mayne Pharma launches Tolsura capsules in the US

    Pharma |  News | 0 Comment | 30 Jan, 2019

    Australia-based Mayne Pharma is pleased to announce the launch of TOLSURA (SUBA®-itraconazole) 65mg capsule in the United States. TOLSURA is a new formulation of itraconazole indicated ...Read more

  • Strides to acquire remaining stake in Vivimed

    Pharma |  News | 0 Comment | 30 Jan, 2019

    Strides Pharma Science Limited has announced that the Board of Directors of Strides and its step down subsidiary Strides Pharma Global Pte Limited, Singapore have approved to convert their ...Read more

Podcast

 

Survey Box

Is Asia Pacific anticipated to be the fastest growing blockchain in healthcare market?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls